VRPX Virpax Pharmaceuticals, Inc.
Healthcare$0.00+0.00%ClosedMarket Cap: $124
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.00
P/S
0.00
EV/EBITDA
0.13
DCF Value
$0.36
FCF Yield
-13478145161.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-2364.8%
ROA
-775.7%
ROIC
1322.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $0.00 | NaN% | $-3.4M | $-3.4M | $— | — |
| FY null | $0.00 | NaN% | $-12.1M | $-12.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.9M | $-2.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.5M | $-3.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.3M | $-3.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.7M | $-4.6M | $— | — |
| FY null | $0.00 | NaN% | $-15.7M | $-15.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-6.1M | $-6.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.2M | $-3.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.7M | $-1.4M | $— | — |
| Q4 2022 | $0.00 | NaN% | $-3.1M | $-2.9M | $-2.45 | — |
| FY null | $0.00 | NaN% | $-21.8M | $-21.5M | $— | — |